FDA reports new deaths with diabetes drug Byetta

August 18, 2008 By MATTHEW PERRONE , AP Business Writer

(AP) -- Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths continue to be reported despite earlier government warnings.

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Similar stories from PHYSorg:

FDA notes heart events, tumors with Novo drug

Mar 31, 2009 | not rated yet | 0

Exenatide promotes weight loss when added to diet and exercise

Jun 11, 2009 | not rated yet | 0

Is inhaled insulin delivery still a possibility? Why has it been a commercial failure?

Sep 23, 2009 | not rated yet | 0

FDA: Bristol-Myers diabetes drug appears safe

Mar 30, 2009 | not rated yet | 0

FDA orders overdose warnings for Darvocet

Jul 07, 2009 | not rated yet | 0

Rate this story - 4.1 /5 (7 votes)

rank
1
2
3
4
5

view popular

Move the slider to adjust rank threshold, so that you can hide some of the comments.

Display comments: newest first

Sepp - Aug 18, 2008
- Rank: 5 / 5 (1)
Pretty bad when a drug for a condition that can be controlled by dietary means causes people to die of pancreatitis. What does the FDA? Require a warning.

In contrast, when a natural nutrient product causes similar trouble, the answer is usually to ban that product outright.

Double standard?
- report abuse
- - Current rank
  - 1
  - 2
  - 3
  - 4
  - 5

Other News

New cancer target for non-Hodgkin's lymphoma

Medicine & Health / Cancer

1hour ago | not rated yet | 0

Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...

Gene mismatch influences success of bone marrow transplants

Medicine & Health / Genetics

1hour ago | not rated yet | 0

A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Ge ...

New understanding about mechanism for cell death after stroke leads to possible therapy

Medicine & Health / Research

2 hours ago | not rated yet | 0

Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which ...

Surface bacteria maintain skin's healthy balance

Medicine & Health / Research

2 hours ago | not rated yet | 0

On the skin's surface, bacteria are abundant, diverse and constant, but inflammation is undesirable. Research at the University of California, San Diego School of Medicine now shows that the normal bacteria living on the ...

Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer

Medicine & Health / Cancer

1hour ago | not rated yet | 0

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough ...